Medstart ApS: Financial statements 2025
CVR: 42857319
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Medstart ApS (CVR 42857319) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,436,998 and a net result of DKK 2,949 compared with DKK -263,017 the year before. That is an increase of 72.7% compared with the year before. Equity in the 2025 report amounted to DKK -114,607. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,436,998
- Profit/Loss
- DKK 2,949
- Equity
- DKK -114,607
- Total Assets
- DKK 159,005
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.4 mio. | 3 t. | -115 t. | 2 |
| 2024 | - | 832 t. | -263 t. | -118 t. | 1 |
| 2023 | - | 2.1 mio. | 695 | 145 t. | 1 |
Official annual report
How creditworthy is Medstart ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Medstart ApS has published its annual report for 2024. Gross profit came to DKK 832,208, and the net result was DKK -263,017.
About Medstart ApS
Medstart ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2021. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Fredrik Bertil Meurling. The board consists of Fredrik Bertil Meurling (chair) and Eva Karin Maria Flaig. The company is owned by Yazen Health AB. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,436,998 and a net result of DKK 2,949 compared with DKK -263,017 the year before. Equity in the 2025 report amounted to DKK -114,607.